Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.